Peer Review History

Original SubmissionMarch 25, 2024
Decision Letter - Palash Chandra Banik, Editor

PONE-D-24-11475Disability and depression among stroke survivors attending rehabilitation facilities at three designated tertiary care hospitals in Bangladesh: A cross-sectional studyPLOS ONE

Dear Dr. Ahmed,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Palash Chandra Banik, MPhil

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

3. We are unable to open your Supporting Information file [Disability and depression.sav  ]. Please kindly revise as necessary and re-upload.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: A good study with a sound study design which addresses an important issue in LMICs. Suggest language editing so that it meets international standards. The limitations section can be expanded. The predictors of depression can be analysed more scientifically.

Reviewer #2: Review Comments to the Author

Thank you for the opportunity to review the manuscript titled “Disability and depression among stroke survivors attending rehabilitation facilities at three designated tertiary care hospitals in Bangladesh: A cross-sectional study.” Please see my points below.

Abstract:

1) Revise the background of the abstract as follows” Poststroke depression (PSD) is a highly prevalent and serious mental health condition affecting a significant proportion of stroke survivors worldwide. While its exact causes remain under investigation, managing PSD presents a significant challenge”.

2) Revise “Depression and disability were measured using the Patient Health Questionnaire-9 and Modified Rankin Scale” with “Depression and disability were measured using the Patient Health Questionnaire-9 and the Modified Rankin Scale, respectively”

3) Authors stated “58.1% of them experienced a moderate to significant level of depression”. What does significant means here. It should be severe/extremely severe or something like that.

4) Revise “ Participants whose medical expenses not participants who had.

5) Rewrite the conclusion section. This part should include a brief summary of all the findings along with recommendations based on the data.

Introduction:

1. While the global context is important, consider emphasizing the urgency of understanding depression in Bangladeshi stroke patients due to limited data (lines 74-75).

2. Strengthen the transition by explicitly stating how your study addresses the identified gap (line 76).

3. Consider combining lines 61-63 to improve readability.

Methodology

1. Add reliability statistics for the modified Rankin scale (mRS) and The Patient Health Questionnaire-9 (PHQ-9) for the current study.

2. Add Hosmer–Lemeshow test value for the present study

3. Add VIF values in the respective table as a new column.

4. While the exclusion criteria are clear, some might be subjective (e.g., communication challenges).

5. While experience is mentioned, it would be beneficial to specify if data collectors received training on using the questionnaires and ensuring consistency.

6. The manuscript should address how missing data (if any) was handled during analysis.

7. Further details on the type and duration of rehabilitation services received could be helpful.

Results:

1. In Table 1, note where you performed the Fisher's Exact test and the Chi-square test.

2. The authors reported Prevalence of disability and depression in the "Prevalence of disability and depression among stroke survivors" section. However, I failed to find any supporting tables or figures in the manuscript.

3. Cite the table number in the section on factors associated with depression among stroke survivors.

4. The section titled "Correlation between disability and depression" does not appear to have any supporting tables or figures.

Discussion:

1. The authors compared the prevalence to two studies in the first section of the discussion, but a more comprehensive comparison is required. Also, simply showing similarities with previous studies is insufficient here.

2. The second paragraph of the discussion seems peculiar to me. Authors must identify the significant variables within their study and rigorously compare them to those identified in other relevant studies. This comparative analysis should be closely aligned with the study objectives and framed within the context of existing literature. By delineating the key variables and exploring how they intersect with those identified in prior research, authors can elucidate the underlying mechanisms driving their findings and contextualize their contribution to the field.

3. Lines 256–264 compared the results to numerous other investigations. The authors should provide a thorough explanation for the observed similarities and differences between their findings and those of previous studies.

4. I found some other factors associated with depression and align with study objectives not discussed in the discussion section.

5. In my opinion discussion section need extensive revisions before considering publication in the PLOS ONE.

6. The "Importance and clinical significance for public health" section warrants a more specific and rigorous treatment, augmented by thorough referencing to substantiate its claims. It is essential to provide a comprehensive analysis of the practical implications of the study's findings within the realm of public health. the authors should strive to enrich this section with precise, evidence-based insights that resonate with the overarching objectives of the study and contribute meaningfully to the advancement of public health knowledge and practice.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Chathurie Suraweera

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reply to the reviewer’s comments

We express our gratitude to the reviewer for their meticulous and in-depth reading of this manuscript, as well as for their insightful remarks and helpful recommendations, all of which have enabled us to enhance the text's quality.

Reviewer # 1

Comment No: 1 A good study with a sound study design which addresses an important issue in LMICs. Suggest language editing so that it meets international standards. The limitations section can be expanded. The predictors of depression can be analysed more scientifically.

Reply No: 1 We appreciate the insightful feedback and the chance to improve the quality of our manuscript. We have now ensured the correctness of the linguistic issue and expanded the limitation section. The multivariate analysis included the variables that showed significant results in the bivariate study.

Reviewer # 2

We express our gratitude to the reviewer for their meticulous and comprehensive evaluation of this paper, as well as for their insightful remarks and valuable recommendations, which significantly contributed to enhancing the overall quality of this work.

Abstract

Comment No: 1 Revise the background of the abstract as follows” Poststroke depression (PSD) is a highly prevalent and serious mental health condition affecting a significant proportion of stroke survivors worldwide. While its exact causes remain under investigation, managing PSD presents a significant challenge”.

Reply No: 1 Thank you for your insightful comment. We have modified the statement in the revised text.

Comment No: 2 Revise “Depression and disability were measured using the Patient Health Questionnaire-9 and Modified Rankin Scale” with “Depression and disability were measured using the Patient Health Questionnaire-9 and the Modified Rankin Scale, respectively”

Reply No: 2 Thank you for your comment. The revised text has been modified according to your suggestion.

Comment No: 3 Authors stated “58.1% of them experienced a moderate to significant level of depression”. What does significant means here. It should be severe/extremely severe or something like that.

Reply No: 3 Thank you for highlighting our unintentional mistake. We have resolved the issue in the revised text.

Comment No: 4 Revise “Participants whose medical expenses not participants who had.

Reply No: 4 We appreciate your attention in this matter and your contribution to improving the quality of our text. We have corrected the issue in the revised text.

Comment No: 5 Rewrite the conclusion section. This part should include a brief summary of all the findings along with recommendations based on the data.

Reply No: 5 Thank you for your suggestion. As per your recommendation, we have now corrected the conclusion section in the revised text.

Introduction

Comment No: 1 While the global context is important, consider emphasizing the urgency of understanding depression in Bangladeshi stroke patients due to limited data (lines 74-75).

Reply No: 1 Addressed in the revised text.

Comment No: 2 Strengthen the transition by explicitly stating how your study addresses the identified gap (line 76).

Reply No: 2 Thank you for your comment, The following statement has been added in the revised text: ‘’This study focused on evaluating the prevalence of depression and exploring the relationship between disability and depressive symptoms among Bangladeshi stroke survivors which will help establish the urgency of intervention in this emerging field. Additionally, this study also identified predictors of depression among Bangladeshi stroke survivors. The results are anticipated to play a crucial role in providing valuable insights for both clinical practices and health policy, ultimately enhancing the mental well-being of stroke survivors in Bangladesh.’’

Comment No: 3 Consider combining lines 61-63 to improve readability.

Reply No: 3 Thank you for your suggestion. The following modification has been added in the revised text ‘’The incidence of depression following a stroke range from 25% to 79%, with more than half of these individuals going undiagnosed or untreated.’’

Methodology

Comment No: 1 Add reliability statistics for the modified Rankin scale (mRS) and The Patient Health Questionnaire-9 (PHQ-9) for the current study.

Reply No: 1 In response to your comment, we have added reliability statistics to the revised text for the modified Rankin scale and the Patient Health Questionnaire-9.

Comment No: 2 Add Hosmer–Lemeshow test value for the present study

Reply No: 2 Added in the revised text

Comment No: 3 Add VIF values in the respective table as a new column.

Reply No: 3 Thank you for your comment. We have added a new column to Table 2 that represents the VIF value.

Comment No: 4 While the exclusion criteria are clear, some might be subjective (e.g., communication challenges).

Reply No: 4 Patients with stroke who experienced speech difficulties and were unable to communicate with the data collector during the interview process were excluded.

Comment No: 5 While experience is mentioned, it would be beneficial to specify if data collectors received training on using the questionnaires and ensuring consistency.

Reply No: 5 Thank you for your comment, The following statement is added in the revised text; ‘’Prior to data collection, a training session was conducted to demonstrate data collection process and maintain consistency among the data collectors.’’

Comment No: 6 The manuscript should address how missing data (if any) was handled during analysis.

Reply No: 6 Thank you for highlighting this issue. The following statement has been added in the revised text: ‘’As there was no missing data, this study includes a total of 725 people, including both males and females, participated in this study.’’

Comment No: 7 Further details on the type and duration of rehabilitation services received could be helpful.

Reply No: 7 Participants in this study were those who received physiotherapy and rehabilitation services at three tertiary care hospitals in Sylhet city at least two weeks prior to events. Unfortunately, we did not consider any variables regarding the duration and type of rehabilitation service received.

Results

Comment No: 1 In Table 1, note where you performed the Fisher's Exact test and the Chi-square test.

Reply No: 1 Thank you for your comment. We added the footnote # denoting Fisher’s exact test, and the remaining variables are Chi-square tests.

Comment No: 2 The authors reported Prevalence of disability and depression in the "Prevalence of disability and depression among stroke survivors" section. However, I failed to find any supporting tables or figures in the manuscript.

Reply No: 2 There is no supporting table for the data, but we did include them in the main analysis and represent them in text form.

Comment No: 3 Cite the table number in the section on factors associated with depression among stroke survivors.

Reply No: 3 Thank you for your comment, added in the revised text.

Comment No: 4 The section titled "Correlation between disability and depression" does not appear to have any supporting tables or figures.

Reply No: 4 There is no supporting table for the data, but we did include them in the main analysis and represent them in text form.

Discussion

Comment No: 1 The authors compared the prevalence to two studies in the first section of the discussion, but a more comprehensive comparison is required. Also, simply showing similarities with previous studies is insufficient here.

Reply No: 1 Thank you for your valuable comment which helps to improve the quality of the manuscript. The following lines are added in the revised text: In their study, Islam et al. found a substantial correlation between depression and living in a joint family, the inability to independently undertake daily living tasks, and having dysphasia [14]. According to another study conducted in Bangladesh, the prevalence of anxiety and depression was more than twenty times higher among individuals who did not receive rehabilitation services [24]. However, a comprehensive analysis and synthesis of other studies found that the occurrence of depression just after a stroke was 27%, and three months after a stroke it increased to 53%, which is slightly less than what our study observed [25].

Comment No: 2 The second paragraph of the discussion seems peculiar to me. Authors must identify the significant variables within their study and rigorously compare them to those identified in other relevant studies. This comparative analysis should be closely aligned with the study objectives and framed within the context of existing literature. By delineating the key variables and exploring how they intersect with those identified in prior research, authors can elucidate the underlying mechanisms driving their findings and contextualize their contribution to the field.

Reply No: 2 Thank you for your valuable feedback. We now ensure that the upgraded manuscript fulfills your expectations.

Comment No: 3 Lines 256–264 compared the results to numerous other investigations. The authors should provide a thorough explanation for the observed similarities and differences between their findings and those of previous studies.

Reply No: 3 The revised text has upgraded the statement as per your suggestion.

Comment No: 4 I found some other factors associated with depression and align with study objectives not discussed in the discussion section.

Reply No: 4 Thank you for your in-depth review and for giving us the opportunity to improve the manuscript's quality. As per your recommendation, we now include medical expenses, care provider, and living arrangements in the discussion section. The following statements has been added in the revised text: Family function and post-stroke depression are significantly associated. Dysfunctional family acting as a stimulus for triggering post-stroke depression [37]. In this present study, stroke survivors who are living with their spouse and children had significantly lower odds of being developed depression. Wang et al. reported in their study that having a well-functioning family is an important protective factor against post stroke depression [37]. Social support helps to prevent post stroke depression and negatively associated with depression among stroke patients [38]. Relationship with spouse and children improve the overall health and life satisfaction of stroke survivors reported in a nationwide cross-sectional study conducted in China [39]. In this study, stroke survivors who received care and medical expenses from their spouse and children had two- and six-times respectively lower odds of developing depression than those who received care and expenses from others.

Comment No: 5 In my opinion discussion section need extensive revisions before considering publication in the PLOS ONE.

Reply No: 5 Thank you for your feedback. We now ensure that the upgraded manuscript will satisfy your recommendations.

Comment No: 6 The "Importance and clinical significance for public health" section warrants a more specific and rigorous treatment, augmented by thorough referencing to substantiate its claims. It is essential to provide a comprehensive analysis of the practical implications of the study's findings within the realm of public health. the authors should strive to enrich this section with precise, evidence-based insights that resonate with the overarching objectives of the study and contribute meaningfully to the advancement of public health knowledge and practice.

Reply No: 6 Thank you for your feedback. We now ensure that the upgraded manuscript will satisfy your recommendations.

Decision Letter - Palash Chandra Banik, Editor

PONE-D-24-11475R1Disability and depression among stroke survivors attending rehabilitation facilities at three designated tertiary care hospitals in Bangladesh: A cross-sectional studyPLOS ONE

Dear Dr. Ahmed,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Palash Chandra Banik, MPhil

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The design, settings, periods and participants are well described

The eligibility criteria are properly addressed

Outcome variables are described and used appropriate tool for data collection. The Statistical methods employed is sufficient. Nevertheless, Authors need to describe how data quality was assured (mention pretesting, standardization of data collection method, was training given etc. The key findings are summarized with reference to study objectives

The strength and limitations of the study is well described, taking into account sources of potential bias or imprecision.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: Yes: Jemal Haidar Ali (Prof)

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: jeviwer_j-stroke-1.docx
Revision 2

Reply to the reviewer’s comments

We express our gratitude to the reviewer for their meticulous and in-depth reading of this manuscript, as well as for their insightful remarks and helpful recommendations, all of which have enabled us to enhance the text's quality.

Reviewer # 3

We express our gratitude to the reviewer for their meticulous and comprehensive evaluation of this paper, as well as for their insightful remarks and valuable recommendations, which significantly contributed to enhancing the overall quality of this work.

Title and Abstract

Comment No: 1 Title is clear and addressed an important issue of health significance. Abstract is structured and presented the findings though the world limit exceeded 300.

Reply No: 1 Thank you for your insightful feedback. In compliance with the journal guidelines, we have decreased the word count to 300.

Introduction

Comment No: 2 The scientific background and rationale is well addressed. Objectives Clear and concise

Reply No: 2 Thank you for your valuable comment

Methodology

Comment No: 3

The design, settings, periods and participants are well described

The eligibility criteria are properly addressed

Outcome variables are described and used appropriate tool for data collection. The Statistical methods employed is sufficient

Nevertheless, Authors need to describe how data quality was assured (mention pretesting, standardization of data collection method, was training given etc…

Reply No: 3 Thank you for your positive feedback. The following statements has been added in the revised text: The interviews were performed by three proficient data collectors, all of whom were physiotherapy graduates with more than three years of experience. Prior to data collection, a training session was conducted to demonstrate data collection process and maintain consistency among the data collectors. In order to address any issues that may arise during data collection, each data collector carried out a pre-test session including a minimum of five data. These data were excluded from the final analysis.

Results

Comment No: 4 Surprising to see 100.0% response rate? How this was possible given the study is facility based and sometimes we see missing information? Elaborate on this further to ensure the credibility of the work.

Report numbers of individuals including the percentages and use appropriate scientific language

Reply No: 4 We appreciate you posing this inquiry and affording us the chance to provide reasonable justifications. Our data collection process utilized the echo-friendly Google Forms platform as an alternative to traditional pen and paper methods. The inclusion of the mandatory option on each question serves to avoid incomplete submissions.

Discussion

Comment No: 5 The key findings are summarized with reference to study objectives

The strength and limitations of the study is well described, taking into account sources of potential bias or imprecision.

Reply No: 5 Thank you for your positive feedback.

Other information

Comment No: 6 Authors need to acknowledge all who assisted/participated in tins study

Reply No: 6 That material has already been provided in the acknowledgement section.

Comment No: 7 Mention the contribution of authors

Reply No: 7 Your insightful remark is appreciated. The information has already been incorporated into the journal system in accordance with the prescribed guidelines of the journal.

Comment No: 8 Interestingly, authors have attached the raw data

Reply No: 8 Raw data was included as per journals requirement

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Palash Chandra Banik, Editor

Disability and depression among stroke survivors attending rehabilitation facilities at three designated tertiary care hospitals in Bangladesh: A cross-sectional study

PONE-D-24-11475R2

Dear Dr. Ahmed,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Palash Chandra Banik, MPhil

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Palash Chandra Banik, Editor

PONE-D-24-11475R2

PLOS ONE

Dear Dr. Ahmed,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Palash Chandra Banik

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .